Clinical Trial Update: Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity [NA]

View source ↗

Summary

A completed clinical trial update reports that dopamine and opioid receptor antagonists reduce cue-induced reward responding and reward impulsivity in individua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Addiction
• Substance Use Disorder

Snippet

Sponsor: University of Zurich | Conditions: Addiction | NA | Status: COMPLETED